查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542775

冠狀動脈繞道手術手術（CABG）的全球市場

Coronary Artery Bypass Grafts (CABG)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球冠狀動脈繞道手術繞道手術 (CABG) 市場預計將達到 2.33 億美元

2023年全球冠狀動脈繞道手術手術（CABG）市場預計為1.702億美元，預計2030年將達到2.33億美元，預測2023-2030年的複合年成長率為4.6%。非體外循環 CABG 是本報告分析的細分市場之一，預計複合年成長率為 4.1%，到分析期結束時將達到 1.091 億美元。在分析期間，體外循環 CABG 領域的複合年成長率預計為 3.3%。

美國市場預估4,600萬美元，中國預期複合年成長率4.2%

預計 2023 年美國冠狀動脈繞道手術手術 (CABG) 市場規模將達到 4,600 萬美元。中國作為全球第二大經濟體，預計2030年市場規模將達3,660萬美元，2023-2030年分析期間複合年成長率為4.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.4% 和 3.6%。在歐洲，德國的複合年成長率預計為 3.8%。

全球冠狀動脈繞道手術(CABG) 市場 – 主要趨勢與促進因素總結

當心臟叛逆時：現代生活如何引發心臟疾病

心臟疾病（CHD）是現代文明最嚴峻的健康挑戰之一，與久坐、不良飲食習慣和高壓力等現代生活方式密切相關。冠心病是全球主要死亡原因，代表了工業化和城市化造成的致命後果，都市化創造了有害心血管健康的環境。加工食品消費量增加、體力活動減少和接觸污染等因素顯著增加了這種疾病的發生率，使其成為重大公共衛生危機。這種疾病不僅給個人和家庭帶來巨大的情緒和經濟負擔，也給世界各地的醫療系統帶來巨大壓力。隨著社會的不斷發展，必須透過公共衛生努力、改善生活方式和獲得優質醫療保健來解決冠心病的根源，以減少其對現代文明的影響。

冠狀動脈繞道手術手術如何徹底改變心臟照護？

冠狀動脈繞道手術手術（CABG）是一種重要的外科手術，用於改善嚴重心臟疾病（CHD）患者心臟的血流。當冠狀動脈因斑塊積聚而變得硬化和狹窄時，就會發生冠心病，從而減少流向心臟的血液並可能導致心臟病發作。 CABG 涉及透過從身體另一部位取出血管並將其移植到阻塞上方或下方的冠狀動脈來繞過阻塞。這使得血液繞過堵塞並到達心肌。冠狀動脈繞道手術已被證明是一種有效的挽救生命的手術，特別是對於多發性冠狀動脈阻塞或其他治療方法不足的患者，可以使他們享受更好的生活品質並降低心臟病的風險。

CABG 手術有何進展？

CABG 手術的最新進展顯著提高了成功率和患者預後。其中一項重大創新是非非體外迴圈冠狀動脈繞道手術手術（OPCAB）的發展，它允許在心臟跳動時進行手術，從而無需心肺機。此手術可減少與心肺體外迴圈相關的併發症，例如認知能力下降和中風。微創直接冠狀動脈繞道手術手術（MIDCAB）是另一項進步，它使用較小的切口而不是切開胸壁，通常需要機器人輔助，從而提供更高的精度和更快的恢復時間。這些技術進步使冠狀動脈繞道手術（CABG）對患者來說更容易取得、難度較低，顯著縮短術後恢復時間，並提高手術的整體效果。

患者和外科醫生在冠狀動脈繞道手術中面臨哪些挑戰？

儘管冠狀動脈繞道手術取得了進步，但仍存在影響患者和外科醫生的重大挑戰。主要挑戰之一是手術期間或手術後可能發生的併發症風險，例如感染疾病、腎衰竭和心肌梗塞。移植的長期成功也是一個問題。這是因為隨著時間的推移，移植物可能會變得更窄，需要重複手術。從外科醫師的角度來看，手術的複雜性需要高水準的技能和經驗，尤其是OPCAB和MIDCAB等新手術，可能並非所有醫院都能提供。此外，針對個別患者最合適的手術方法的決策流程需要仔細考慮多種因素，包括患者的健康狀況、動脈閉塞的嚴重程度以及是否存在其他醫療狀況。

是什麼推動了冠狀動脈繞道手術市場的成長？

冠狀動脈繞道手術手術市場的成長是由多種因素推動的，例如全球人口老化以及肥胖、吸菸和缺乏運動等生活方式因素導致的心血管疾病盛行率的增加。醫學影像技術的進步也發揮著重要作用，因為它們改善了 CHD 的診斷和 CABG 等外科手術的規劃。此外，更新、更先進的移植物生物材料的開發提供了更好的貼合性和耐用性，正在推動移植物的採用不斷增加。隨著新興市場經濟成長改善醫療基礎設施並提高先進手術技術的可用性，全球範圍內進行的冠狀動脈繞道手術數量不斷增加。此外，旨在提高冠狀動脈繞道手術的有效性和安全性的持續臨床研究和臨床試驗也促進了該市場的強勁成長。綜合這些因素，CABG仍然是心臟疾病的基本治療選擇，反映了其在現代心臟治療中的重要角色。

調查企業範例（共41例）

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding BV & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP11336

Global Coronary Artery Bypass Grafts (CABG) Market to Reach US$233.0 Million by 2030

The global market for Coronary Artery Bypass Grafts (CABG) estimated at US$170.2 Million in the year 2023, is expected to reach US$233.0 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Off-Pump CABG, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$109.1 Million by the end of the analysis period. Growth in the On-Pump CABG segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$46.0 Million While China is Forecast to Grow at 4.2% CAGR

The Coronary Artery Bypass Grafts (CABG) market in the U.S. is estimated at US$46.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$36.6 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Coronary Artery Bypass Grafts (CABG) Market - Key Trends and Drivers Summarized

When Hearts Rebel: How Modern Life Fuels the Fire of Coronary Heart Disease

Coronary heart disease (CHD) stands as one of the most formidable health challenges of modern civilization, closely linked to contemporary lifestyles characterized by sedentary behavior, poor dietary habits, and high stress. As the leading cause of death globally, CHD epitomizes the lethal consequences of industrialization and urbanization which promote environments detrimental to cardiovascular health. Factors such as increased consumption of processed foods, reduced physical activity, and exposure to pollution have substantially elevated the incidence of this disease, marking it as a critical public health crisis. This condition not only places a significant emotional and financial burden on individuals and families but also exerts immense pressure on healthcare systems worldwide. As societies continue to evolve, addressing the root causes of CHD through public health initiatives, improved lifestyle choices, and access to quality healthcare becomes imperative to alleviate its impact on modern civilization.

How Is Coronary Artery Bypass Grafting Revolutionizing Cardiac Care?

Coronary Artery Bypass Grafting (CABG) is a critical surgical procedure used to improve blood flow to the heart in patients with severe coronary heart disease (CHD). CHD occurs when the coronary arteries become hardened and narrowed due to the buildup of plaque, reducing blood flow to the heart and potentially leading to a heart attack. CABG involves taking a blood vessel from another part of the body and grafting it to the coronary artery above and below the blocked area, thus bypassing the blockage. This allows blood to flow around the obstruction and reach the heart muscle. CABG has proven to be an effective life-saving procedure, particularly for patients with multiple blocked coronary arteries and those who have not responded well to other treatments, offering them a higher quality of life and reduced symptoms of heart disease.

What Advancements Are Shaping CABG Techniques?

Recent advancements in CABG techniques have significantly enhanced the success rates and patient outcomes. One of the major innovations is the development of off-pump coronary artery bypass (OPCAB), which allows surgeons to perform the procedure while the heart is still beating, eliminating the need for a heart-lung machine. This technique reduces complications associated with cardiopulmonary bypass, such as cognitive decline and stroke. Minimally invasive direct coronary artery bypass (MIDCAB) is another advancement that uses smaller incisions rather than opening the chest wall and often involves robotic assistance, which provides greater precision and faster recovery times. These technological advancements have made CABG more accessible and less daunting for patients, significantly reducing postoperative recovery time and improving the overall efficacy of the procedure.

What Challenges Do Patients and Surgeons Face with CABG?

Despite the advancements in CABG techniques, there are still significant challenges that affect both patients and surgeons. One of the main challenges is the risk of complications, which can include infections, kidney failure, and heart attacks during or after surgery. The long-term success of the grafts is also a concern, as they can become narrowed over time, potentially leading to a repeat surgery. From a surgeon's perspective, the technical complexity of the procedure requires high skill and experience, particularly with newer techniques like OPCAB and MIDCAB, which may not be available in all hospitals. Additionally, the decision-making process regarding the most appropriate surgical approach for each individual patient involves careful consideration of various factors, including the patient’s health status, the severity of artery blockage, and the presence of other medical conditions.

What Drives the Growth in the Coronary Artery Bypass Graft Market?

The growth in the coronary artery bypass graft market is driven by several factors, including an aging global population and an increase in the prevalence of cardiovascular diseases, driven by lifestyle factors such as obesity, smoking, and physical inactivity. Advances in medical imaging technologies have also played a significant role, as they have improved the diagnosis of CHD and the planning of surgical interventions like CABG. Furthermore, the development of newer, more advanced biomaterials for grafts that offer better compatibility and durability is encouraging their increased adoption. Economic growth in emerging markets has led to improved healthcare infrastructure and access to advanced surgical techniques, thereby increasing the number of CABG procedures performed worldwide. Additionally, ongoing clinical research and trials aimed at enhancing the efficacy and safety of CABG contribute to the robust growth of this market. Together, these factors ensure that CABG remains a cornerstone treatment option for coronary heart disease, reflecting its vital role in contemporary cardiac care.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Coronary Artery Bypass Grafts (CABG) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Coronary Artery Disease Propels Demand for CABG
    • Advancements in Minimally Invasive Surgery Techniques Expand Market Reach
    • Aging Population Globally Drives Need for Effective CABG Procedures
    • Rising Healthcare Expenditure and Insurance Coverage Bolster CABG Accessibility
    • Emerging Markets Witness Increased Adoption of Advanced Cardiac Care
    • Cardiac Rehabilitation Developments Post-CABG Surgery Support Patient Recovery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Coronary Artery Bypass Grafts (CABG) Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Off-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for On-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Minimally Invasive Direct by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Saphenous Vein Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Internal Thoracic Artery Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • CHINA
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030

IV. COMPETITION